Experience

Orgenesis Inc.

• United States
• Biotechnology
• 1 - 100 Employee

• Senior Director of Immunotherapy

  • Oct 2020 - Present



Cell Cure Neurosience

• VP Research

  • Mar 2018 - Mar 2020

  CellCure Neurosciences – a subsidiary of Lineage Cell Therapeutics, Inc., is a clinical- stage company developing cell therapies for retinal and neural degenerative diseases. VP Research – In charge of all company’s research and pre-clinical strategic and plans. Leading the company's new technologies, pipeline and future product portfolio. Involve in management strategic and business plans. Manage the research teams, Advising and supporting the clinical team, In charge of US/IL tech transfer, coordinate between company's departments and implementation of a complex cell therapy product toward commercial, GLP manufacturing process. Show less



Raziel Therapeutics

• Hadassah Ein Kerem, Jerusalem

• VP Research and Development

  • May 2016 - Mar 2018

  Raziel Therapeutics – a clinical-stage pharmaceutical company developing a proprietary small molecule for fat reduction. VP Research and Development- in charge of all R&D programs including pre-clinical studies. Scientific company representative in the board of directors, involved in company's strategic plan, management of the CMC and subcontractors, elucidation of product mode of action, Overseeing the diligent preparation and filing of regulatory submissions to support the on-going clinical study. Initiation of new pipeline toward execution of phase II clinical trials. Advising management on regulations, corporate responsibility, compliance and audit preparation. Show less



Cellect Bio Inc

• United States
• Biotechnology Research

• VP Research and Development

  • Mar 2014 - May 2016

  Cellect Biotechnology focuses its resources to the development of hematopoietic cell product for GVHD. VP R&D, Regulatory and Clinical Affairs – leading the product from an innovative idea to the phase II clinical trials. Responsible for all research and development activities, new animal models establishment, managing new process and method development and implementations toward GMP manufacturing. Established and implemented all the laboratory infrastructure setup including employee's recruitment, SOP’s, equipment etc. In charge of conduct of all non-clinical studies, writing and submission of clinical and regulatory documents toward phase- I/IIa clinical trial. Show less



UroGene Ltd

• Raanana, Israel

• Director of Research & Pre-Clinical Affairs

  • Jul 2012 - Mar 2014

  UroGene (TheraCoat Ltd) – a clinical stage pharmaceutical company develops a drug delivery and retention systems to be combined with therapeutics for the treatment of urinary tract malignancies. Director of Research and Pre-Clinical affairs – In charge of all company’s research and pipeline strategies compliance with the business plans. Responsible for the design, implementation and performance of pre-clinical efficacy and safety studies and management of subcontractors. In charge of new indication development including collaboration with medical advisors, development of novel animal models and preparation for submission for the FDA. Involved in the clinical trial strategic planning and counter partner for the company's new IP. Show less



Nephera

• Director of Scientific and Pre-clinical Affairs

  • Jul 2011 - Nov 2012

  Nephera Ltd - Medical device company dedicated to improve renal function for congestive heart failure disorders. Director of Scientific and Pre-Clinical Affairs – successfully designing and implementing all company’s efficacy and safety pre-clinical studies towards the first-in-man clinical trial. In addition, I was counter partner for clinical trials and regulatory strategic planning. Nephera Ltd - Medical device company dedicated to improve renal function for congestive heart failure disorders. Director of Scientific and Pre-Clinical Affairs – successfully designing and implementing all company’s efficacy and safety pre-clinical studies towards the first-in-man clinical trial. In addition, I was counter partner for clinical trials and regulatory strategic planning.



Pluri

• Israel
• Biotechnology Research
• 100 - 200 Employee

• Research Director

  • Mar 2006 - Nov 2010

  Pluristem Therapeutics Inc - Bio-therapeutics company dedicated to the commercialization of allogeneic cell therapy products for the treatment of a variety of severe disorders. Director of Research – Responsible for all research activities, pre-clinical studies, new methods development, and implementation. In charge of searching for new indications and scientific collaborations. Responsible for potency assays development, research of product unique mode of action, new assay development and optimization, running of the day-to-day laboratory activities. Involved in due diligence process with international pharmaceutical company. In addition, a counter partner for regulatory affairs and the company's patents and IP strategy. Show less